Louisbourg Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
9,986
-11,030
-52% -$2.57M 0.43% 76
2026
Q1
$4.41M Sell
21,016
-11,896
-36% -$2.77M 0.83% 52
2025
Q4
$5.67M Sell
32,912
-6,660
-17% -$1.32M 1.13% 31
2025
Q3
$5.91M Sell
39,572
-2,540
-6% -$435K 1.29% 27
2025
Q2
$5.2M Buy
42,112
+1,795
+4% +$276K 1.23% 28
2025
Q1
$5.27M Sell
40,317
-7,385
-15% -$1.16M 1.43% 20
2024
Q4
$5.37M Buy
47,702
+3,055
+7% +$473K 1.41% 20
2024
Q3
$5.9M Sell
44,647
-60
-0.1% -$9.56K 1.49% 18
2024
Q2
$5.28M Buy
44,707
+3,100
+7% +$461K 1.48% 20
2024
Q1
$5.38M Buy
41,607
+5,106
+14% +$813K 1.49% 27
2023
Q4
$4.8M Buy
+36,501
New +$5.6M 1.45% 19

Other funds holding JNJ

Louisbourg Investments's JNJ Position: Q2 2026 in Review

Louisbourg Investments reduced its Johnson & Johnson (JNJ) stake by 52% in Q2 2026, selling an estimated $2.57M and leaving 9,986 shares worth $2.33M. The position accounts for 0.43% of the portfolio, ranked #76.

Louisbourg Investments first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.91M in Q3 2025. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Louisbourg Investments held 9,986 shares of Johnson & Johnson worth $2.33M as of Q2 2026.
  • Louisbourg Investments sold 11,030 Johnson & Johnson shares in Q2 2026, an estimated $2.57M.
  • Johnson & Johnson made up 0.43% of Louisbourg Investments's portfolio in Q2 2026, its #76 holding.
  • Louisbourg Investments first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Louisbourg Investments's Johnson & Johnson position peaked at $5.91M in Q3 2025.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.